Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06644664 · ClinicalTrials.gov registry record · NA

Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers

A NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06644664: Active NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT06644664 is a NA study of Tobacco-Related Carcinoma that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 300 participants, below the 1,479-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06644664, a NA study of Tobacco-Related Carcinoma, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates the effect of message framing on smoking behaviors among lesbian, gay, bisexual, transgender, queer (LGBTQ+) young adults who use nicotine and/or tobacco. Tobacco regulation has contributed to a steady decline in tobacco products designed to be smoked (combustible), but there has been an increase in the use of new tobacco products, such as electronic nicotine delivery systems (ENDS). The use of more than one tobacco product (polytobacco) is high in LGBTQ+ populations. Both LGBTQ+ people and people who engage in polytobacco use are less likely to view tobacco as harmful, which may reinforce tobacco use. Message framing includes culturally targeted messages to communicate the absolute risks (AR) and relative risks (RR) of polytobacco use. Using message framing may increase quit rates or change smoking behaviors in LGBTQ+ young adults who use nicotine and/or tobacco products.

Primary Outcome

2 items. Asks for current use of nicotine vapes and combustible cigarettes Every day, Some days, or Not at all.

Conditions Studied

Interventions

  • BEHAVIORAL Smoking Cessation Intervention
  • OTHER Interview
  • BEHAVIORAL Health Education

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-09-24
Est. Completion 2026-12-31
Phase NA

What the registry record for NCT06644664 still lists

NCT06644664 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,479-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Smoking Cessation Intervention is the first listed.

NCT06644664 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06644664 about?

NCT06644664 is a clinical study titled "Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers". This clinical trial evaluates the effect of message framing on smoking behaviors among lesbian, gay, bisexual, transgender, queer (LGBTQ+) young adults who use nicotine and/or tobacco. Tobacco regulation has contributed to a steady decline in tobacco products designed to be smoked (combustible), but...

What is the current status of trial NCT06644664?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-09-24. Estimated completion is 2026-12-31.

What conditions does trial NCT06644664 study?

This clinical trial studies the following conditions: Tobacco-Related Carcinoma.

What interventions are being tested in trial NCT06644664?

The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Interview (OTHER), Health Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06644664?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06644664 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06644664's enrollment target sits among peer trials

300 8th of 10 higher than 3 of 10 other Tobacco-Related Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06644664, the US trial registry maintained by the National Library of Medicine. NCT06644664 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.